Compared with patients whose HBcrAg level was less than 10 KU/mL, a level of 10-99 KU/mL was associated with a nearly threefold increase in risk for hepatocellular carcinoma (HR, 2.93).
A positive dose-response relationship exists between the number of insomnia symptoms and the risk of cardiocerebral vascular disease, according to a large cohort study.